NIH-Funding

Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R01 Clinical Trial Optional)

NIH Funding Announcements - Fri, 11/03/2017 - 10:49
Funding Opportunity PA-18-005 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to promote research on interventions, based in healthcare settings, designed to reduce overscreening for breast, cervical, or colorectal cancers among average-risk older adults. While ongoing efforts to promote screening have been successful, there is growing concern that these tests may be overused, thereby subjecting adults to unnecessary risks. Overscreening older adults may be driven by factors at the individual, healthcare team, healthcare system and community organization levels. Therefore, research is needed both to understand the factors that drive overuse and to develop and test interventions that will reduce overuse in healthcare delivery systems. Research supported by this FOA should propose to intervene at two or more levels, and should measure outcomes at two or more levels, while accounting for interactions that occur between levels. Research supported by this FOA should enhance knowledge and consequences of overscreening to improve the health, independence, and quality of life of older adults.
Categories: NIH-Funding

Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R01 Clinical Trial Optional)

NIH Funding Announcements - Fri, 11/03/2017 - 10:46
Funding Opportunity PA-18-004 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to encourage research grant applications to: (1) assess and describe the current state of oral anticancer medication utilization, delivery, and adherence; (2) identify structural, systemic, and psychosocial barriers to adherence; and (3) develop models and strategies to improve safe and effective delivery of these agents so that clinical outcomes are optimized. Applications should focus research questions on at least one of the following: specific cancer type; class of drugs; and/or groups subject to disparities (e.g., elderly populations, members of low socioeconomic groups, racial/ethnic minorities). Research may be focused at the patient (pediatric, adolescent, or adult), patient-caregiver, provider, health care team, or health care delivery system level, and may include intervention studies, observational studies, or mixed-methods studies. Observational studies should emphasize modifiable risk factors for future intervention research.
Categories: NIH-Funding

Notice of NIMH Participaton in (PA-18-345) NIH Research Project Grant (Parent R01 Clinical Trial Required)

NIH Funding Announcements - Fri, 11/03/2017 - 03:37
Notice NOT-MH-18-006 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

NCCIH Policy for Submission of Parent R01 Applications Proposing Clinical Trials

NIH Funding Announcements - Fri, 11/03/2017 - 03:37
Notice NOT-AT-18-001 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

NIH Research Project Grant (Parent R01 Clinical Trial Required)

NIH Funding Announcements - Fri, 11/03/2017 - 03:36
Funding Opportunity PA-18-345 from the NIH Guide for Grants and Contracts. The NIH Research Project Grant supports a discrete, specified, circumscribed project in areas representing the specific interests and competencies of the investigator(s). This Parent Funding Opportunity Announcement requires that at least 1 clinical trial be proposed. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions. Applicants should note that some ICs (see Related Notices) only accept applications proposing mechanistic studies that meet NIH's definition of a clinical trial through this funding opportunity announcement.
Categories: NIH-Funding

NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)

NIH Funding Announcements - Fri, 11/03/2017 - 03:36
Funding Opportunity PA-18-344 from the NIH Guide for Grants and Contracts. The NIH Exploratory/Developmental Grant supports exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research. This Parent Funding Opportunity Announcement requires that at least 1 clinical trial be proposed. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions. Applicants should note that some ICs (see Related Notices) only accept applications proposing mechanistic studies that meet NIH's definition of a clinical trial through this funding opportunity announcement.
Categories: NIH-Funding

Academic Research Enhancement Award (R15 Clinical Trial Required)

NIH Funding Announcements - Fri, 11/03/2017 - 03:08
Funding Opportunity PA-18-343 from the NIH Guide for Grants and Contracts. The purpose of the Academic Research Enhancement Award (AREA) program is to stimulate research in educational institutions that provide baccalaureate or advanced degrees for a significant number of the Nation's research scientists, but that have not been major recipients of NIH support. AREA grants create opportunities for scientists and institutions otherwise unlikely to participate extensively in NIH research programs to contribute to the Nation's biomedical and behavioral research effort. AREA grants are intended to support small-scale research projects proposed by faculty members of eligible, domestic institutions, to expose undergraduate and/or graduate students to meritorious research projects, and to strengthen the research environment of the applicant institution.
Categories: NIH-Funding

By: writedit

WriteEdit-Grant Questions Blog - Thu, 11/02/2017 - 23:06

Only your PO can tell you if you can feel cautiously optimistic (and only after you receive your summary statement), but that score is certainly in their funding zone, especially if the FY18 budget keeps the slight increase anticipated for the NIH. Your PO will know after reviewing the summary statement whether there might be any caveats affecting your funding likelihood.

Categories: NIH-Funding

Closing February and March 2018 Application Receipt Dates for PAR-12-200 Occupational Safety and Health Research (R03)

NIH Funding Announcements - Thu, 11/02/2017 - 13:40
Notice NOT-OH-18-005 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

Closing February and March 2018 Application Receipt Dates for PAR-13-245 Mentored Research Scientist Development Award (K01)

NIH Funding Announcements - Thu, 11/02/2017 - 13:17
Notice NOT-OH-18-004 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

Closing February and March 2018 Application Receipt Dates for PAR-12-252 NIOSH Exploratory/Developmental Grant Program (R21)

NIH Funding Announcements - Thu, 11/02/2017 - 13:10
Notice NOT-OH-18-007 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

Closing February and March 2018 Application Receipt Dates for PAR-13-129 Occupational Safety and Health Research (R01)

NIH Funding Announcements - Thu, 11/02/2017 - 13:02
Notice NOT-OH-18-006 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

NCCIH Mind and Body Clinical Trial Cooperative Agreement (U01 Clinical Trial Required)

NIH Funding Announcements - Thu, 11/02/2017 - 11:45
Funding Opportunity PAR-18-118 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites cooperative agreement applications for investigator-initiated clinical trials of mind and body interventions in NCCIH-designated areas of high research priority. Applications submitted under this FOA are expected to propose a clinical trial to develop and test adaptive interventions; optimize the intervention by evaluating which element of a complex intervention are critical for changes in outcome; assessing whether the intervention can be delivered with fidelity across sites in preparation for a future multi-site trial; or collect additional preliminary data such as determining the duration or frequency of the intervention to be used in a future multi-site trial. It is important, therefore, to already have sufficient preliminary data that includes: demonstration of feasibility of recruitment and accrual of participants; demonstration of participant adherence to the intervention as well as retention of participants throughout the study; completion of final data collection from any related studies; and evidence that the intervention has promise of clinical benefit. This FOA is not intended to support multi-site efficacy or effectiveness trials, nor will it support trials to test mind and body interventions for the treatment or prevention of cancer.
Categories: NIH-Funding